Skip to main navigation Skip to search Skip to main content

Longitudinal voxel-based FDG PET assessment of chemotherapy effects on brain metabolism in lung cancer

  • Hao Wen Cheng
  • , Ing Tsung Hsiao
  • , Tsai Wang Huang
  • , Yueh Lee
  • , Qing Fang Yang
  • , I. Feng Chen
  • , Chuang Hsin Chiu
  • , Cheng Yi Cheng
  • , Li Fan Lin*
  • *Corresponding author for this work
  • National Defense University Taiwan
  • Chang Gung University

Research output: Contribution to journal › Journal Article › peer-review

Abstract

Background: Chemotherapy-induced cognitive impairment (CICI) is a frequently reported complication in lung cancer patients, yet the underlying cerebral metabolic changes remain poorly characterized. This study aimed to evaluate chemotherapy-related alterations in brain glucose metabolism in patients with non-small cell lung cancer (NSCLC) using a longitudinal, within-subject voxel-based 18F-FDG PET approach. Methods: Forty NSCLC patients who underwent both pre- and post-chemotherapy FDG PET imaging were retrospectively enrolled. Voxel-wise comparisons were performed using SPM12 to identify regional metabolic changes. Patients were stratified based on chemotherapy intensity (standard: ≥4 cycles; short-course: 1–3 cycles) and recovery interval (short: <6 months; long: ≥6 months), with subgroup and interaction analyses conducted accordingly. Results: Compared with baseline, post-treatment scans revealed regional metabolic reductions, predominantly in the right thalamus, left frontal lobe, and bilateral temporal regions. Patients receiving standard chemotherapy exhibited more extensive metabolic reductions than those receiving short-course treatment, particularly in the bilateral temporal and cingulate regions. Furthermore, patients scanned within six months post-chemotherapy showed more pronounced reductions than those with longer recovery intervals, suggesting a potential trend of metabolic recovery over time. In contrast, patients with limited initial metabolic changes (i.e., short-course group) exhibited minimal changes across intervals. Conclusion: This within-subject FDG PET study provides longitudinal evidence that chemotherapy independently contributes to brain metabolic alterations in NSCLC patients, predominantly involving the frontal, temporal, and limbic regions. These findings highlight vulnerable neural substrates and underscore the clinical value of functional neuroimaging in cancer survivorship research.

Original languageEnglish
Article number111817
JournalBrain Research Bulletin
Volume237
DOIs
StatePublished - 04 2026

Bibliographical note

Publisher Copyright:
© 2026 The Authors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Brain Metabolism
  • Chemotherapy
  • Cognitive Impairment
  • FDG PET
  • NSCLC
  • Voxel-Based Analysis

Fingerprint

Dive into the research topics of 'Longitudinal voxel-based FDG PET assessment of chemotherapy effects on brain metabolism in lung cancer'. Together they form a unique fingerprint.

Cite this